Ensign Group, Inc
ENSGNasdaqCIK 1125376HealthcareFiscal year ends Dec 31
Reports and events: 250 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2716:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-26-000047 |
| 2026-10-2716:05 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001125376-26-000046 |
| 2026-08-2516:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001125376-26-000040 |
| 2026-08-2016:09 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001125376-26-000038 |
| 2026-07-2706:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-26-000036 |
| 2026-07-2706:02 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001125376-26-000034 |
| 2026-06-1516:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001125376-26-000031 |
| 2026-06-1021:14 ET | 8-K | 8.01 Other events | 0001125376-26-000029 |
| 2026-05-1816:04 ET | 8-K | 5.07 Shareholder vote results | 0001125376-26-000026 |
| 2026-04-3016:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-26-000023 |
| 2026-04-3016:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001125376-26-000021 |
| 2026-04-0216:04 ET | DEF 14A | Proxy statementPeriod 2026-05-13 | 0001125376-26-000014 |
| 2026-02-0416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-26-000008 |
| 2026-02-0416:04 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001125376-26-000007 |
| 2025-11-0316:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-25-000171 |
| 2025-11-0316:04 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001125376-25-000170 |
| 2025-08-2616:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001125376-25-000158 |
| 2025-07-2416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-25-000143 |
| 2025-07-2416:04 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001125376-25-000142 |
| 2025-06-2016:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001125376-25-000115 |
| 2025-05-2016:03 ET | 8-K | 5.07 Shareholder vote results | 0001125376-25-000085 |
| 2025-04-2916:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-25-000076 |
| 2025-04-2916:03 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001125376-25-000075 |
| 2025-04-0416:04 ET | DEF 14A | Proxy statementPeriod 2025-05-15 | 0001125376-25-000055 |
| 2025-02-0516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-25-000023 |
| 2025-02-0516:03 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001125376-25-000021 |
| 2024-10-2416:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-24-000172 |
| 2024-10-2416:04 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001125376-24-000171 |
| 2024-10-2120:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001125376-24-000166 |
| 2024-07-2516:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-24-000136 |
| 2024-07-2516:04 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001125376-24-000135 |
| 2024-05-1716:12 ET | 8-K | 5.07 Shareholder vote results | 0001125376-24-000074 |
| 2024-05-0116:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-24-000065 |
| 2024-05-0116:02 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001125376-24-000064 |
| 2024-04-0516:05 ET | DEF 14A | Proxy statementPeriod 2024-05-16 | 0001125376-24-000045 |
| 2024-02-0116:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-24-000019 |
| 2024-02-0116:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001125376-24-000018 |
| 2023-10-2516:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-23-000185 |
| 2023-10-2516:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001125376-23-000184 |
| 2023-07-2716:16 ET | 8-K/A | 5.07 Shareholder vote results | 0001125376-23-000151 |
| 2023-07-2716:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-23-000150 |
| 2023-07-2716:03 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001125376-23-000149 |
| 2023-05-1916:55 ET | 8-K | 5.07 Shareholder vote results | 0001125376-23-000095 |
| 2023-04-2616:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-23-000089 |
| 2023-04-2616:04 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001125376-23-000088 |
| 2023-04-0718:18 ET | DEF 14A | Proxy statement | 0001125376-23-000066 |
| 2023-02-0216:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-23-000019 |
| 2023-02-0216:01 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001125376-23-000018 |
| 2022-12-2216:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001125376-22-000153 |
| 2022-10-2616:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125376-22-000141 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:27 ET. Listed shows no prices and gives no investment advice.